StonvexLoading…
StonvexStonvexStonvexCore line items from GCTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.87M | $9.13M | $16.03M |
Operating Income | $-36.54M | $-13.12M | $-14.56M |
Net Income | $-43.37M | $-12.38M | $-22.47M |
EPS (Diluted) | $-0.82 | $-0.30 | $-0.94 |
Total Assets | $15.64M | $19.90M | $16.43M |
Total Liabilities | $98.94M | $79.21M | $131.87M |
Cash & Equivalents | $590.00K | $1.44M | $258.00K |
Free Cash Flow OCF − CapEx | $-33.09M | $-31.50M | $-9.16M |
Shares Outstanding | 58.14M | 47.99M | 24.17M |